AstraZeneca’s vaccine has brought in $275 million in sales so far this year.

The New York Times – Business:

The company has pledged not to profit from its vaccine during the pandemic. Governments have been paying several dollars per dose.

Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.